The PennZone

  • Home
  • Business
  • Health
  • Financial
  • Construction
  • Automotive
  • Technology
  • Music
  • Arts

Greenphire Enhances Patient Convenience Solutions, Supporting Clinical Trial Sites with Recruitment and Retention Worldwide
The PennZone/10123847

Trending...
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library
  • Thirteen Reasons Why Gyminny Kids Is San Diego's Best Gymnastics Gym
KING OF PRUSSIA, Pa., May 4, 2021 /PRNewswire/ -- Greenphire, the global leader in financial lifecycle management for clinical trials, today announced sharp growth of its patient convenience solutions, ClinCard and ConneX, worldwide. The company, which now serves investigator sites in more than 70 countries, also made strategic enhancements to its solutions that support adoption, training, and usage of technologies.

ConneX®,  the trusted participant travel service designed to eliminate logistical barriers to participation in global clinical trials, has now facilitated travel in 34 countries, with the ability to arrange travel and accommodations worldwide. Notably, after going live with in-country support in China, Greenphire has already executed more than 200 patient itineraries. In addition, the number of studies using ConneX increased by 62% and the number of itineraries by 40% since the start of 2020, with notable increases in France and Russia.

Greenphire has also continued to evolve its ClinCard solution, the industry-leading method for automating participant payments and reimbursements, driving operational efficiency for sites and improved experience for participants around the world. The ClinCard portal is now translated into 17 different languages, including French, Polish, and Spanish. The company also initiated a dedicated site training team with EU and APAC time zones supported, demonstrating its commitment and motivation to provide a high quality and user-friendly experience for sites around the world.

More on The PennZone
  • She's Been Ready for Weeks, He Starts in the Final 72 Hours – The Great Christmas Shopping Divide
  • Following a Global Sell-Out, The World's No.1 Superstar™ Unveils a Fashion Line Rebrand
  • IDCXS Exchange Founder Travels to Angola for Strategic Cooperation Talks
  • 2026 NBA Mock Draft: New Wave of Franchise Talent Emerges in Early Lottery Projections
  • Bad Bunny Leads 2026 Grammys Album of the Year Odds, Lady Gaga Emerges as Top Challenger

"COVID-19 was a catalyst that accelerated the clinical trial industry towards embracing technology solutions, such as ClinCard and ConneX," said Jim Murphy, CEO, Greenphire. "Sponsors, CROs and sites quickly appreciated the immense benefits of adding innovative solutions to support their trials, such as higher patient engagement and retention and improved operational efficiencies. We are proud to support this digital movement and enhance the experience for sites in every corner of the globe."

Recognized as leaders in clinical digital innovations in the United Kingdom, having their EU headquarters in Nottingham and more than 1,000 sites supported in the country, Greenphire executives have been asked to host an interactive panel on this growing trend.

Hosted by the Society for Clinical Research Sites (SCRS), the one-hour session titled: Digital Innovation in Clinical Trials: A Conversation with UK Stakeholders, will also feature the unique perspectives of clinical trial site, The University of Aberdeen, and advocate and patient engagement advisor, Trishna Bharadia.

This virtual event is scheduled for May 4, 2021 at 10:00 AM ET and will take a deep dive into current trends and how technology, together with training, is driving the future of clinical trials.

Presenters include:
  • Angela La Ronde, Panel Moderator, Director of Relationship Management, Greenphire UK
  • Trishna Bharadia, Advocate and Patient Engagement Advisor
  • Shaun Treweek, Professor, University of Aberdeen
  • Ben Gordon, Site Trainer, Greenphire UK

For more information or to register for the event visit: https://bit.ly/3tLmfws

More on The PennZone
  • Metro Detroit teen Lola Winters turns viral TikTok fame into a sold-out clothing brand
  • ReedSmith® Celebrates Innovative Founders at TCVN's Survivor™ XII at SoCal Startup Day
  • The global race for next-gen precious metals recovery is accelerating: $AABB is positioning itself with it's Revolutionary rGO Gold Recovery System
  • NorthSky Celebrates One-Year Anniversary
  • Free At Last Bail Bonds Gives Back Through Major Holiday Food Distribution Efforts Across Metro Atlanta

Greenphire is also a co-sponsor of the 11th Annual OCT Europe (Outsourcing in Clinical Trials). The virtual event, hosted from May 5-6, 2021, will center on how to leverage partnerships and expertise to maximize trial success. For more information, visit: https://www.arena-international.com/octeurope/

About Greenphire
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire's EnvisiXTM, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

Media Contact:
Alyson Kuritz
908-892-7149
[email protected]

SOURCE Greenphire

Related Links

http://www.greenphire.com
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Bent Danholm Releases New Video Breaking Down the Rising Debate Over 50-Year Mortgages
  • New Smile Now Introduces RAYFace 3D Scanner to Advance Digital Surgery
  • Ali Alijanian, DDS Featured in The Profitable Dentist Magazine
  • "Meet the Eatmons" Offer Financial Advice ahead of the Holidays
  • CCHR: Study Finds Involuntary Commitment Fails to Prevent Suicide, Raises Risk
  • Slotozilla's Q3 2025: SBC Lisbon Outcomes and Partnership Expansion
  • Historic Announcement for the Global Car Rental Industry
  • Siembra Brings 18 Latinx Artists Together in Brooklyn Exhibition
  • Gramercy Tech Launches StoryStream
  • Entrigue Magazine LLC Announces Strategic Media Partnership with Reewind Network LLC
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • Outreaching.io Appoints Rameez Ghayas Usmani as CEO, Recognized as Best HARO Link Building Expert in the United States
  • Winzele: A Trusted Isolation Transformer Manufacturer
  • Luxury Mediterranean Estate in Gotha Sells for $1.52 Million, Closing $45,000 Over Asking
  • ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
  • UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library

Popular on PennZone

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 455
  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - From College Blogger to Successful Entrepreneur
  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation
  • Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines
  • 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
  • The OpenSSL Corporation and the OpenSSL Foundation Celebrate the Success of the Inaugural OpenSSL Conference in Prague
  • Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field

Similar on PennZone

  • CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
  • 2026 NBA Mock Draft: New Wave of Franchise Talent Emerges in Early Lottery Projections
  • ReedSmith® Celebrates Innovative Founders at TCVN's Survivor™ XII at SoCal Startup Day
  • Free At Last Bail Bonds Gives Back Through Major Holiday Food Distribution Efforts Across Metro Atlanta
  • Uk Financial Ltd Provides Investors Of Maya Preferred & Mayacat Instructions For Upcoming First Ever Listing Of Both Erc-3643 "SEC-Ready" Tokens
  • Bahamas Import Assistant Launches Same-Day Pet Permit Service Under BAHFSA's 2024 Expansion
  • Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
  • "Meet the Eatmons" Offer Financial Advice ahead of the Holidays
  • Slotozilla's Q3 2025: SBC Lisbon Outcomes and Partnership Expansion
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us